Business
uniQure Reports Strong Phase I/II Results for AMT-130 in Huntington's Disease
7 sources
•
Nov 10, 2025
Business
Venus Concept Gains FDA Nod for Cutting-Edge NOVA Aesthetic Treatment Platform
5 sources
•
Nov 10, 2025
Health
"New Analysis Confirms VASCEPA® Efficacy in Reducing Heart Risks at AHA 2025"
6 sources
•
Nov 9, 2025
Business
FDA Denies Biohaven's VYGLXIA Application for Spinocerebellar Ataxia Treatment
7 sources
•
Nov 5, 2025
Business
TScan Therapeutics Streamlines Workforce 30% as FDA Advances Heme Therapy Development
6 sources
•
Nov 3, 2025
Business
Benitec Biopharma Shares Surge 20% Following FDA Fast Track for OPMD Treatment
5 sources
•
Nov 3, 2025
United States
Scott Adams Urgently Seeks Trump’s Help in Fight Against Advanced Prostate Cancer
1 sources
•
Nov 2, 2025
United States
FDA Drug Chief Suspended Amid Claims of 'Toxic' Political Influence on Approvals
1 sources
•
Nov 2, 2025
United States
FDA Eases Rules to Accelerate Approval of Affordable Biosimilar Drugs
1 sources
•
Oct 29, 2025
Business
Regeneron Reports Q3 2025 Growth Amid Strong Dupixent Sales and FDA Approval
5 sources
•
Oct 28, 2025
Business
Genentech's Gazyva Gains FDA Nod for Lupus Nephritis, Boosting Roche's Portfolio
9 sources
•
Oct 20, 2025
United States
Kotak and Motilal Mutual Funds Inject Rs 169 Crore into Rubicon Research Ahead of IPO
1 sources
•
Oct 9, 2025